Peregrine Asset Advisers, Inc. Dexcom Inc Transaction History

Peregrine Asset Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$67.99 - $132.89 $41,745 - $81,594	-614 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $79,740 - $99,971	614 New	614 $330,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $556,823 - $658,498	-5,830 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $365,424 - $614,132	5,830 New	5,830 $2.36 Million

1,021

352M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.